This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / 23andMe Files for Bankruptcy
Business bankruptcy filing

23andMe Files for Bankruptcy

Analysis based on 46 articles · First reported Mar 24, 2025 · Last updated Mar 27, 2025

Sentiment
-80
Attention
6
Articles
46
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The bankruptcy filing of 23andMe has caused its shares to plunge significantly, reflecting a loss of investor confidence and concerns over its business model and data privacy. This event highlights the risks associated with the at-home DNA testing industry, potentially impacting other companies in the sector and raising broader questions about data security and consumer trust.

Biotechnology Healthcare Data Security
Event Summary

23andMe, a genetic testing company, filed for Chapter 11 bankruptcy protection in Missouri federal court. This move aims to facilitate a sale process to maximize the value of its business. Co-founder and CEO Anne Wojcicki resigned, though she remains on the board and plans to pursue the company as an independent bidder. The bankruptcy follows years of financial struggles, including a significant data breach in 2023 that exposed data of nearly 7 million customers, mass layoffs of 40% of its workforce, and the discontinuation of its therapeutics division. The company's market valuation has plummeted from a peak of $6 billion to approximately $25 million. GHO Capital Partners has committed $35 million in debtor-in-possession financing to support 23andMe's operations during the bankruptcy. United States — California Attorney General Rob Bonta issued a consumer alert, urging customers to consider deleting their genetic data due to privacy concerns.

Key Actions
100 23andMe filed for bankruptcy
82 Anne Wojcicki resigned as CEO 23andMe
80 23andMe laid off employees
75 23andMe discontinued division
75 23andMe settled lawsuit
60 GHO Capital Partners committed financing 23andMe
55 Rob Bonta issued consumer alert 23andMe
Entities Involved
stock
23andMe
23andMe filed for Chapter 11 bankruptcy protection, seeking to sell its assets and restructure its business after years of financial struggles, a significant data breach, and declining market value. Its CEO also resigned.
Importance 100.0 Sentiment -90.0
per
Anne Wojcicki
Anne Wojcicki resigned as CEO of 23andMe but remains on the board, expressing her intent to pursue the company as an independent bidder after her previous acquisition proposals were rejected.
Importance 90.0 Sentiment -70.0
per
Rob Bonta
Rob Bonta, the United States — California Attorney General, urged 23andMe users to delete their genetic data due to privacy concerns arising from the bankruptcy and potential sale of the company.
Importance 60.0 Sentiment 20.0
priv
GHO Capital Partners
GHO Capital Partners committed $35 million in debtor-in-possession financing to 23andMe, supporting its operations during the bankruptcy process.
Importance 40.0 Sentiment 10.0
per
Joe Selsavage
Joe Selsavage, the CFO of 23andMe, will serve as interim CEO during the restructuring process following Anne Wojcicki's resignation.
Importance 20.0 Sentiment 0.0
per
Mark Jensen
Mark Jensen, Chair of 23andMe's board, stated that a court-supervised sale is the best path to maximize business value and ensure data privacy.
Importance 20.0 Sentiment 0.0
ngo
Consumer Reports
Consumer Reports' Ginny Fahs highlighted the valid concerns users have about their genetic data being used in unexpected ways if 23andMe is sold.
Importance 10.0 Sentiment 0.0
stock
GSK plc
GSK plc had a high-profile collaboration with 23andMe for pharmaceutical research, which ultimately did not meet expectations, contributing to 23andMe's financial decline.
Importance 10.0 Sentiment 0.0
loc
United States — California
The United States — California Attorney General, Rob Bonta, issued a consumer alert regarding 23andMe's financial distress and potential risks to customer data, highlighting United States — California's robust privacy laws.
Importance 10.0 Sentiment 0.0
priv
FamilyTreeDNA
FamilyTreeDNA is mentioned as one of the sites where users can upload their 23andMe data, offering an alternative for genetic data analysis.
Importance 5.0 Sentiment 0.0
priv
MyHeritage
MyHeritage is mentioned as one of the sites where users can upload their 23andMe data, providing an alternative for genetic data analysis.
Importance 5.0 Sentiment 0.0
priv
GEDmatch
GEDmatch is mentioned as one of the sites where users can upload their 23andMe data, offering an alternative for genetic data analysis.
Importance 5.0 Sentiment 0.0
priv
Living DNA
Living DNA is mentioned as one of the sites where users can upload their 23andMe data, providing an alternative for genetic data analysis.
Importance 5.0 Sentiment 0.0
priv
Ancestry.com
Ancestry.com, a major genetics and family history service, is noted for not accepting 23andMe data.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.